| Catalog No. |
Size |
Price |
Figures |
A00124-100 ug
| 100 ug | $ 165.00 | MSDS: 20081020032729 (PDF)
References:
- Clavey V, et al. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E. Arterioscler. Thromb Vasc. Biol. Jul 1995; 15(7): 963-971.
|
|---|
| Full Name | | Goat Anti-Human Apo CIII Polyclonal Antibody |
|
| Alias | Goat Anti-Human Apo CIII pAb |
|---|
| Abbreviated Name-2 | Anti Human Apo CIII |
|---|
| Description | At least 9 distinct polymorphic forms of apolipoproteins are known. The apolipoproteins act as stabilizers of the intact lipoprotein particles. Quantitative measurements of HDL, LDL and VLDL particles in human serum are often used to estimate an individuals' relative risk of coronary heart disease. In addition, quantitative immunological measurements of certain apolipoproteins (especially A1 and B) have been suggested to be more accurate estimators of coronary heart disease than measurements of lipoprotein particles (especially HDL and LDL).
|
|---|
| Storage | Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing. Aliquot will be stable at 4°C for 3 months. |
|---|
| Specificity | Specifically binds to human apo CIII. |
|---|
| Concentration | 1 mg/ml, PBS, pH 7.4 with 0.05% sodium azide. |
|---|
| Immunogen | Apo CIII recombinant protein |
|---|
| Purification Method | Immunoaffinity purification |
|---|
| Applications | Western blot: 1:2,500-1:20,000
ELISA: 1:2,500-1:20,000 |
|---|
| Conjugation | Unconjugated |
|---|
| Species Reactivity | Human |
|---|
| Host Species | Goat |
|---|
| Antigen Species | Human |
|---|
| Note | Briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container's cap because small volumes of antibody will occasionally become entrapped in the seal of the product vial during shipment and storage. |
|---|
